Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 3
2010 3
2011 6
2013 2
2019 1
2020 5
2021 4
2022 7
2023 10
2024 7
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Circadian desynchrony and glucose metabolism.
Speksnijder EM, Bisschop PH, Siegelaar SE, Stenvers DJ, Kalsbeek A. Speksnijder EM, et al. Among authors: siegelaar se. J Pineal Res. 2024 May;76(4):e12956. doi: 10.1111/jpi.12956. J Pineal Res. 2024. PMID: 38695262 Review.
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets.
Benhalima K, Beunen K, Siegelaar SE, Painter R, Murphy HR, Feig DS, Donovan LE, Polsky S, Buschur E, Levy CJ, Kudva YC, Battelino T, Ringholm L, Mathiesen ER, Mathieu C. Benhalima K, et al. Among authors: siegelaar se. Lancet Diabetes Endocrinol. 2023 Jul;11(7):490-508. doi: 10.1016/S2213-8587(23)00116-X. Epub 2023 Jun 5. Lancet Diabetes Endocrinol. 2023. PMID: 37290466 Review.
Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial.
Rademaker D, de Wit L, Duijnhoven RG, Voormolen DN, Mol BW, Franx A, DeVries JH, Painter RC, van Rijn BB; SUGAR-DIP Study Group; Siegelaar SE, Akerboom BMC, Kiewiet-Kemper RM, Verwij-Didden MAL, Assouiki F, Kuppens SM, Oosterwerff MM, Stekkinger E, Diekman MJM, Vogelvang TE, Belle-van Meerkerk G, Galjaard S, Verdonk K, Lub A, Klooker TK, Krabbendam I, van Wijk JPH, Huisjes AJM, van Bemmel T, Nijman RGW, van den Beld AW, Hermes W, Johannsson-Vidarsdottir S, Vlug AG, Dullemond RC, Jansen HJ, Sueters M, de Koning EJP, van Laar JOEH, Wouters-van Poppel P, Evers IM, Sanson-van Praag ME, van den Akker ES, Brouwer CB, Hermsen BB, Scholten R, Meijer RI, van Leeuwen M, Wijbenga JAM, Wijnberger LDE, van Bon AC, van der Made FW, Eskes SA, Zandstra M, van Houtum WH, Braams-Lisman BAM, Daemen-Gubbels CRGM, Nijkamp JW, de Valk HW, Wouters MGAJ, IJzerman RG, Reiss I, van der Post JAM, Bosmans JE. Rademaker D, et al. Among authors: siegelaar se. JAMA. 2025 Feb 11;333(6):470-478. doi: 10.1001/jama.2024.23410. JAMA. 2025. PMID: 39761054 Free PMC article. Clinical Trial.
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.
Benhalima K, Beunen K, Van Wilder N, Ballaux D, Vanhaverbeke G, Taes Y, Aers XP, Nobels F, Marlier J, Lee D, Cuypers J, Preumont V, Siegelaar SE, Painter RC, Laenen A, Gillard P, Mathieu C. Benhalima K, et al. Among authors: siegelaar se. Lancet Diabetes Endocrinol. 2024 Jun;12(6):390-403. doi: 10.1016/S2213-8587(24)00089-5. Epub 2024 Apr 30. Lancet Diabetes Endocrinol. 2024. PMID: 38697182 Clinical Trial.
Advanced Hybrid Closed-Loop Therapy Compared With Standard Insulin Therapy Intrapartum and Early Postpartum in Women With Type 1 Diabetes: A Secondary Observational Analysis From the CRISTAL Randomized Controlled Trial.
Beunen K, Gillard P, Van Wilder N, Ballaux D, Vanhaverbeke G, Taes Y, Aers XP, Nobels F, Van Huffel L, Marlier J, Lee D, Cuypers J, Preumont V, Siegelaar SE, Painter RC, Laenen A, Mathieu C, Benhalima K. Beunen K, et al. Among authors: siegelaar se. Diabetes Care. 2024 Nov 1;47(11):2002-2011. doi: 10.2337/dc24-1320. Diabetes Care. 2024. PMID: 39331059 Clinical Trial.
52 results